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Background. At the Clinical Center of Serbia (CCS), which includes 21 Institutes and 6
Centers, approximately 10% of the total annual budgetary funds is spent on the drugs.
During the studied period, it was estimated that 0.5% of the above amount has been spent
at the Institute for Otorhinolaryngology and Maxillofacial surgery (Institute for ORL and
MFS), Clinical Center of Serbia. The aim of this study was to find out if these antibiotics
had been used ratinally by the monitoring of antibiotics in relation to the number of inpa-
tients, and by the 5 most frequent diagnoses. Methods. The authors monitored the tree-year
consumption of antibiotics for inhospital treated patients during the period 2001–2003.
Data were obtained from the itemized quarerly report on the consumption by the Central
Pharmacy of the CCS. Results. The results were statistically analyzed and presented in
percentages and Defined Daily Dasages (DDD) for each group of the antibiotics. The re-
sults were analyzed in accordance with the World Health Organization Recommendations
and the Guidelines. Conclusion. The authors concluded that antibiotics were adequately
used at the Institute for ORL and MFS-CCS. The most commonly used antibiotics for gram-
positive infections were those from the penicillin and cephalosporin groups. According to
the international trends and recommendations, the selected therapy was rational and the
antibiotics consumption was cut down during the observed three-year period. It was a true
confirmation that the recommendations for the rational antibiotics consumption had been
fruitful (produced good results).
K e y   w o r d s : drug administration shedule; drug utilization review;
anti-bacterial drugs; surgery, oral.
Introduction
The Institute of Otorhinolaryngology and Maxillofacial
Surgery, Clinical Center of Serbia (ORL and MFS CCS)
manages diseases and injuries of the upper respiratory tract,
among which the five leading diagnoses are as follows: laryn-
geal tumors, hypopharyngeal tumors, chronic otitis, secondary
otitis and polyps. The most common bacterial floras, which
are the cause of the upper respiratory tract infections in our
patients, are streptococcus,  staphylococcus, enterobacter,
pseudomonas and E. coli. Considering these causative agents,
the selection of drugs within the following antibiotic groups:
penicillins, cephalosporins, aminoglycosides, quinolones, tet-
racyclines and “reserve” antibiotics, was an adequate choice
for our physicians. So, the upper airway infections in our pa-
tients were most frequently caused by gram-positive bacteria,
and, hence, they are our pharmacotherapeutic goal. Antibiot-
ics were used on regular basis, postoperatively for 7 days, and
preoperatively as a prophylaxis in the risk group of patients,
i.e., with the history of presence of bacterial endocarditis. In-
traoperatively, antibiotics were administered in a single dose
in endoscopic interventions (1). Bacteria, which in this region
as well as according to the available literature and our clinical
experience are the common for antibiotic usage, are strepto-
coccus, staphylococcus, enterobacter, pseudomonas and E.
coli (2).
A large number of antibiotics is commercially avail-
able and, thus, the various approaches to their application
are present causing the polypragmatism and the irrational
antibiotic use. The objective of this study was to determine,Страна 552 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Број 7-8
by monitoring the antibiotic consumption at the Institute of
ORL and MFS CCS, whether these antibiotics had been
used in accordance with the current recommendation.
Methods
This paper is a part of the planned six-year prospective
study of the antibiotic consumption monitoring at the Insti-
tute of ORL and MFS CCS, representing the results of the
last three-year period (2001–2003). The epidemiological
protocol specially designed for this study was used. Besides
general informations, the protocol included the following
data: the generic name of antibiotic, the trade mark of anti-
biotic, dosage, the form of drug, the unit packaging, and
quantity of packagings used. The number of patients treated
at the Institute of ORL and MFS CCS, the five most com-
mon diagnoses and the groups of used antibiotics were fol-
lowed up. The choice of the antibiotic group, as well as the
individual antibiotics within the specific group was com-
pared with the European standard (3). In addition, the local
(CCS) guidelines for antimicrobial therapy and the Sanford
Guide to Antimicrobial Therapy were used (4). The used
antibiotics were analyzed in regard to their consumption,
presented by the schedule, percentages and Daily Defined
Dosages (DDD).
Results
Five leading diagnoses followed up during a three-
year period at the Institute of ORL and MFS-CCS, are in
Table 1.
The results suggested that penicillins and cephalospo-
rins had ranked first in regard to the antibiotic consumption
during the entire three-year period (Table 2). In 2002, the
consumption of penicillin was by 7.67% less than in 2001,
while in 2003, the consumption was by 1.22% less than in
2002. On the contrary, cephalosporins consumption was re-
ported to be by 18.33% higher in 2002 in comparison to
2001. In 2003, cephalosporins were used only by 0.2% less
than in 2002. During 2003, cefepime, a 4th generation
cephalosporin, was used according to the drug susceptibility
test for pseudomonas-associated infections. During 2001
and 2002, the groups of quinolones and aminoglycoside an-
tibiotics alternatively took the third and fourth place: in
2001, quinolones were third in regard to the consumption,
which was 16.64%, while in 2002, they took the forth place
and their consumption was reduced by 10.68%; in 2003,
they were not reported among the first five groups of the
used antibiotics. In 2001, aminoglycoside antibiotics took
the fourth place (12.04%), then in 2002, they fell on the
third place due to the increase of the consumption by
0.21%, while in 2003, their consumption at the Institute of
ORL and MFS CCS increased for 1.63% in comparison
with 2002, but they were still third according to the admini-
stration. The tetracycline group of antibiotics was fifth over
the entire five-year period of the observation. Their con-
sumption in clinical practice was 6.67% in 2001, then it was
reduced by 0.85% in 2002, and increased by 0.81% com-
pared to the previous year. In 2003, during the observation
period, the macrolide group of antibiotics was forth for the
first time (9.79%) (Figures 1–3).
The overall antibiotic consumption presented as
DDD/hospital day during the observed period was on the
decrease: in 2001, it was 123.07 DDD/hospital day, in 2002
– 82.52 DDD/ hospital day, and in 2003, a total number of
DDD/hospital day was 57.51.
Table 1
Five most prevalent diagnoses at the Institute of Otorhinolaryngology and
Maxillofacial Surgery, Clinical Center of Serbia
2001 (Total number of inpatients: 3 047)
1 Exploratory laryngomicroscopy with sampling 306 10.04%
2 Tympanoplasty 200 6.56%
3 Laryngectomy 160 5.25%
4 Neck disection 150 4.92%
5 Nasal polyps ablation 122 4.00%
2002 (Total number of inpatients: 3 092)
1 Exploratory laryngomicroscopy with sampling 835 27.00%
2 Laryngectomy 250 8.08%
3 Tympanoplasty 219 7.08%
4 Maxillary sinus trepanation 168 5.43%
5 Vocal cord polyps extirpation 150 4.85%
2003 (Total number of inpatients: 2 971)
1 Tympanopasty 244 8.11%
2 Laryngectomy 235 7.91%
3 Vocal cord polyps extirpation 154 5.18%
4 Nasal polyps ablation 150 5.05%
5 Maxillary sinus trepanation 145 4.88%Број 7-8 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Страна 553
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Fig. 1 – Antibiotic consumption at the Institute of ORL and
MFS CCS in 2001
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Fig. 2 – Antibiotic consumption at the Institute of ORL and
MFS CCS in 2002
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Discussion
The basic principles of rational antibiotic treatment,
with multiple modifications, included several factors (5):
clinical findings, bacteriological test results, causative
agents of infection, the choice of antibiotics, antibiotic
combinations, the dosage regimens, the way of application,
the duration of the therapy, the modification of the initial
therapy as well as the patient’s condition. There was the big
difference between the characteristics of antibiotic pre-
scription in the primary health care, and their usage in the
hospital setting, particularly in clinical centers (6). These
principles were the baseline for making the working
schemes – algorithms; their goal was the effectiveness of
treatment, with the delayed development of bacterial resis-
Table 2
Antibiotic consumption – first 5 groups at the Institute of ORL and MFS-CCS from 2001−2003
Group % DDD/
hospital day
2001  
1 Penicillins: Amoxicillin, Ampicin 34.99 43.06
2 Cephalosporins: Ceftriaxone, Cephalexin, Cefotaxime, Cefuroxime,
Ceftazidime 19.55 24.06
3 Quinolones: Ciprofloxacin 16.64 20.48
4 Aminoglycosides: Gentamicin 12.04 14.82
5 Tetracyclines: Doxycycline 6.67 8.20
6 Others 10.11
2002  
1 Cephalosporins: Cephalexin, Ceftriaxone, Cefotaxime, Ceftazidime 37.88 31.26
2 Penicillins: Amoxicillin + clavulanic acid, Ampicillin 27.32 22.55
3 Aminoglycosides: Amikacin, Gentamicin 12.25 10.11
4 Quinolones: Ciprofloxacin, Ofloxacin 5.96 4.92
5 Tetracyclines: Doxycycline 5.82 4.80
6 Others 10.77
2003
1 Cephalosporins: Cephalexin, Ceftriaxone, Cefotaxime, Ceftazidime 37.68 21.67
2 Penicillins: Amoxicillin, Ampicillin, Amoxicillin + clavulanic acid 26.10 15.01
3 Aminoglycosides: Amikacin, Gentamicin 13.88 7.98
4 Macrolides: Clindamycin, Erythromycin, Lincomycin 9.79 5.63
5 Tetracyclines: Doxycycline 6.63 3.80
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tance and the reduction of the costs. Data on antimicrobial
drug consumption were important, because they indicated
the extent of their probable irrational application.
Our study showed that this antibiotic therapy was ap-
plied according to the drug susceptibility test results, in
compliance with the WHO recommendations and the ap-
plied guidelines for antimicrobial therapy. Within the
structure of antibiotics prescribed in 2001, the predominant
ones were as follows: penicillins, cephalosporins,
quinolones, aminoglycosides, and tetracyclines. Lincomycin
(5.53%, 6.81 DDD), erythromycin and clindamycin (3.05%,
3.75 DDD), sulfamethoxazole + trimethoprim (1.36%, 1.67
DDD), imipenem (0.11%, 0.13 DDD) and vancomycin
(0.07%, 0.09 DDD) were used rarely. In 2001, i.e., within
365 days, 44 920 DDD of antibiotics were spent on 3 047
inpatients, which was around 14 DDD/patient/year. In addi-
tion, in 2001, the number of DDD/day was 123.07 per 140
hospital beds. If one takes into account that there were pa-
tients who received combination of two or three antibiotis,
that nosocomial infections and septic conditions were
treated by antibiotics, and that there were patients from the
smaller hospitals referred to the Institute of ORL and MFS
CCS for further treatment, then it may be concluded that the
consumption of antibiotics was adequate. One must be aware
of the fact that 2001 was the first year after the hard ten-year
period when our physicians were in a position to opt for vari-
ous antibiotics. Gram-positive infections of the upper respi-
ratory tract are generally treated at the Institute of
ORL&MFS, and therefore, the physicians could make the
adequate choice of the aforementioned antibiotics according
to the Sanford guide to antimicrobial therapy and the local
CCS Guides. Due to the pathology of diseases and the head
and neck injuries, the characteristic of antibiotic to pass
through the blood-brain barrier is crucial. Moreover, the peni-
cillin and cephalosporin groups of antibiotics, closely tied for
first place with a consumption during the past years, have the
fast-acting pharmacokinetic characteristics which was very
important for the treatment of our patients (7).
Within the structure of antibiotic consumption in
2002, the predominant ones were: cephalosporins, peni-
cillins, aminoglycosides, quinolones and tetracyclines.
Lincomycin (5.24%, 4.32 DDD), clindamycin and eryth-
romycin (4.29%, 3.54 DDD), streptomycin and rifampicin
(0.99%, 0.82 DDD), imipenem (0.04%, 0.03 DDD) and
vancomycin (0.21%, 0.17 DDD) were used rarely. During
2002, at our institute, a total of 30120 DDD were thera-
peutically applied, which was 9.74 DDD per inpatient. It
clearly indicated that the possibility of choice reduced the
antibiotic consumption i.e., that one was able to choose an
adequate antibiotic to obtain the fastest cure. It led to the
rationalization of antibiopharmacotherapy.  The special-
ists in clinical pharmacology, in compliance with recom-
mendations of the Good Clinical Practice and WHO (8),
also contributed to the implementation of the rational
pharmacotherapeutical standpoints at the CCS Institute of
ORL and MFS.
Of the antibiotics consumed in 2003, the most com-
morly used were as follows: cephalosporins, penicillins,
aminoglycosides, macrolides and tetracyclines. In 2003, ce-
fepime, a 4th generation cephalosporin, was used for the
first time for the treatment of the upper respiratory tract in-
fections caused by pseudomonas, according to the drug sus-
ceptibility test, i.e., in case of the infection of surgical site
wound. The application of quinolones (ciprofloxacin, oflox-
acin) – 4.57% 2.63 DDD, antituberculotics (streptomycin,
rifampicin) – 1.30%  0.75 DDD, and other antibiotics (imi-
penem) – 0.05% 0.04 DDD was rather rare. Within the
group “others”, antibiotics from the so-called “reserve”
group were included (9). During 2003, at our institute, a
total of 20 991 DDD were therapeutically applied, which
was 7.07 DDD/inpatient (Table 3).
Table 3
Antibiotic consumption at the Institute of
Otorhinolaryngology and Maxillofacial Surgery, Clinical
Center of Serbia
Year DDD/year No of patients DDD/patient
2001 44 920 3 047 14.00
2002 30 120 3 092 9.74
2003 20 991 2 971 7.07
Interestingly, the decrease of the number of DDD/day
during a three-year observation period was
123.07 : 82.52 : 57.51 respectively, probably due to the ap-
propriate supply and, hence, to an adequate choice of anti-
biotics as to the well as observation of the instructions for
the rational usage of antibiotics.
The activity of the Center for Clinical Pharmacology,
Clinical Center of Serbia (CCP CCS), includes the prepara-
tion of the priority antibiotic list exclusively based on the to
up-to-date principles of pharmacotherapy regardless of their
position on the negative-or positive-drug list. As a measure
for pharmacotherapeutic rationalization, CCP CCS uses the
practical population pharmacokinetic approach based on the
collection and processing of a rather small number of data
on antibiotic concentrations in our patients. Such monitor-
ing of antibiotic concentrations is the safest measure for
dosage, adequacy control, and the base for the prevention of
bacterial resistance (10).
This work is a part of a six-year study, which goes on,
and upon its completion, the comparative results of antibi-
otic consumption of similar studies will be published.
Conclusion
The results of our study showed that the consumption
of antibiotics at the Institute of ORL and MFS CCS, in the
period 2001 to 2003, was rational, due to the adequate
choice of antibiotics based on the isolated or expected
causative agent, the localization and the severity of infec-
tion and pharmacokinetic drug characteristics. We believed
that it was the result of making a “true” choice of antibiot-
ics, stable domestic drug market in that period, and also ofБрој 7-8 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Страна 555
the implementation of current international recommenda-
tions on antimicrobial therapy. Certainly, much credit was
given to CCP CCS for the rational antibiotic consumption in
our Institute of ORL and MFS CCS, which was an addi-
tional recognition of the role of these centers in the applica-
tion of the rational pharmacotherapy (11).
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Apstrakt
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PRAĆENJE POTROŠNJE ANTIBIOTIKA U INSTITUTU ZA
OTORINOLARINGOLOGIJU I MAKSILOFACIJALNU HIRURGIJU KLINIČKOG
CENTRA SRBIJE U PERIODU OD 2001. DO 2003. GODINE
Uvod. U Kliničkom centru Srbije (KCS), koji u svom sastavu ima 21 institut i 6
centara, u okviru budžeta se na lekove godišnje odvoji 10%. U proseku, u  toku
praćenog perioda, Institut za otorinolaringologiju i maksilofacijalnu hirurgiju (Insti-
tut  za ORL MFH) troši  0,5% od  ovih 10%. Cilj ovoga rada je da se praćenjem
potrošnje antibiotika u odnosu na broj hospitalno lečenih bolesnika i najčešćih pet
dijagnoza ustanovi da li se oni racionalno koriste. Metode. Praćena je potrošnja
antibiotika kod bolnički lečenih bolesnika u periodu od 2001. do 2003. godine. Za
bazu ovih podataka korišćeni su podaci iz izveštaja Centralne apoteke KCS o ut-
rošku antibiotika svakog tromesečja. Rezultati su statistički obrađeni i prikazani
procentualno i u dnevno definisanim dozama (DDD) po grupama antibiotika. Re-
zultati. Na osnovu analize sprovedene u skladu sa preporukama Svetske zdrav-
stvene organizacije (SZO), zaključeno je da su u našem Institutu antibiotici koriš-
ćeni adekvatno. Za gram pozitivne infekcije najčešće korišćeni antibiotici bili su iz
grupe penicilina i cefalosporina. Zaključak. U skladu sa međunarodnim tokovima i
preporukama izabrana terapija je bila racionalna, a potrošnja antibiotika smanjena
u toku tri prikazane godine, što pokazuje da su preporuke za racionalizaciju potro-
šnje antibiotika dale rezultate.
Kl juč ne reč i : lekovi, propisivanje; lekovi, korišćenje, izveštaji;
antibiotici; hirurgija, maksilofacijalna.
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